Internal Medicine, Rheumatology · Asheville, NC
NPI
1033172895
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
4 Vanderbilt Park Dr, Suite 200
Asheville, NC, 28803
Phone (828) 258-9533
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
131,776 services
Medicare patients, 2024
468
Average age 74
Drug cost, 2024
$3.8M
7,457 prescriptions
Company payments, 2025
$28K
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kristin M Gowin was code J3262 (injection, tocilizumab, 1 mg), 66,320 times for 25 patients. In total Kristin M Gowin billed 131,776 services in 98 codes, and Medicare paid $1.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-05-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 66,320 | 25 | $4.69 | $311K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 19,600 | 36 | $9.07 | $178K |
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 11,600 | 13 | $3.60 | $42K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 7,980 | 15 | $8.61 | $69K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 5,700 | 23 | $33.64 | $192K |
| J0897 Injection, denosumab, 1 mg | Office | 5,160 | 59 | $20.65 | $107K |
| 85025 Blood Count | Office | 738 | 248 | $7.50 | $5,537 |
| 86140 Clinical Chemistry | Office | 734 | 256 | $5.01 | $3,680 |
| 85652 Clinical Chemistry | Office | 725 | 256 | $2.63 | $1,906 |
| 82565 Clinical Chemistry | Office | 719 | 265 | $4.95 | $3,557 |
| 99214 Office E&M - Established | Office | 664 | 295 | $86.73 | $58K |
| 80076 Clinical Chemistry | Office | 652 | 219 | $7.88 | $5,138 |
| 36415 Venipuncture Blood Collection | Office | 504 | 213 | $8.63 | $4,351 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 497 | 254 | $11.60 | $5,764 |
| 86160 Immunoassay | Office | 302 | 72 | $11.41 | $3,445 |
By year: 2022 $1.4M for 100,658 services; 2023 $1.2M for 112,174 services; 2024 $1.3M for 131,776 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 738 | 248 | $7.50 | $5,537 |
| 86140 Clinical Chemistry | 734 | 256 | $5.01 | $3,680 |
| 85652 Clinical Chemistry | 725 | 256 | $2.63 | $1,906 |
| 82565 Clinical Chemistry | 719 | 265 | $4.95 | $3,557 |
| 80076 Clinical Chemistry | 652 | 219 | $7.88 | $5,138 |
| 36415 Venipuncture Blood Collection | 504 | 213 | $8.63 | $4,351 |
| 86160 Immunoassay | 302 | 72 | $11.41 | $3,445 |
| 81001 Clinical Chemistry | 140 | 69 | $3.02 | $422 |
| 82570 Clinical Chemistry | 140 | 69 | $4.93 | $690 |
| 82310 Clinical Chemistry | 111 | 78 | $5.01 | $557 |
Medicare prescription drug claims, 2024
In 2024, the drug Kristin M Gowin prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 820 prescriptions and refills. In total Kristin M Gowin wrote 7,457 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 820 | 1,713 | 179 | $24K |
| Prednisone Generic | 460 | 706 | 139 | $2,776 |
| Methotrexate Methotrexate Sodium | 407 | 786 | 91 | $7,136 |
| Tramadol Hcl Generic | 391 | 435 | 85 | $3,057 |
| Celecoxib Generic | 387 | 649 | 83 | $7,247 |
| Meloxicam Generic | 336 | 709 | 91 | $1,877 |
| Gabapentin Generic | 310 | 567 | 75 | $5,882 |
| Duloxetine Hcl Generic | 281 | 556 | 69 | $4,876 |
| Pregabalin Generic | 230 | 306 | 44 | $4,766 |
| Leucovorin Calcium Generic | 213 | 384 | 38 | $4,191 |
| Cyclobenzaprine Hcl Generic | 173 | 287 | 45 | $1,920 |
| Zolpidem Tartrate Generic | 164 | 228 | 28 | $1,032 |
| Sulfasalazine Dr Sulfasalazine | 145 | 270 | 30 | $5,654 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 123 | 123 | 22 | $2,593 |
| Mycophenolate Mofetil Generic | 113 | 148 | 16 | $9,056 |
Brand drugs: 806 claims; generic drugs: 6,636 claims; opioid claims: 585.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kristin M Gowin $28K ($28K in general payments such as food, travel and fees) from 16 companies. The largest payer was Abbvie Inc. with $15K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 37 | $15K |
| Amgen Inc. AMGN | 53 | $11K |
| Janssen Biotech, Inc. JNJ | 9 | $389 |
| E.R. Squibb & Sons, L.L.C. BMY | 23 | $230 |
| UCB, Inc. UCB.BR | 4 | $221 |
| Genzyme Corporation SNY | 3 | $179 |
| Radius Health, Inc. | 4 | $90.65 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $73.97 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $52.03 |
| Pfizer Inc. PFE | 2 | $44.29 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.